Safety and Efficacy of 24-h Closed-Loop Insulin Delivery in Well-Controlled Pregnant Women With Type 1 Diabetes A randomized crossover case series
Helen R Murphy, Kavita Kumareswaran, Daniela Elleri, Janet M Allen, Karen Caldwell, Martina Biagioni, David Simmons, David B Dunger, Marianna Nodale, Malgorzata E Wilinska, Stephanie A Amiel, Roman Hovorka
Diabetes Care | AMER DIABETES ASSOC | Published : 2011
Awarded by Diabetes UK
Awarded by National Institute for Health Research (NIHR)
Awarded by Medical Research Council
Awarded by National Institute for Health Research
This work was funded by a Diabetes UK project grant (BDA 07/003551). H.R.M. was funded by a National Institute for Health Research (NIHR) research fellowship (PDF/08/01/036). The research was conducted with support from the Juvenile Diabetes Research Foundation, Abbott Diabetes Care (Free Style Navigator continuous glucose monitors and sensors), the investigator-initiated study program of the Animas Corporation (Animas 2020 insulin pump), the Medical Research Council Center for Obesity and Related Metabolic Diseases, the NIHR Cambridge Biomedical Research Center, and Addenbrooke's Clinical Research Facility (Cambridge, U.K.). No funder had any role in the study design; data collection, analysis, and interpretation; or manuscript preparation. Ethical approval was received from the Essex 2 Research Ethics Committee (09/H0302/113).H.R.M. has received honoraria for speaking engagements from Medtronic. S.A.A. has received consultancy and lecture fees from Medtronic, Roche, Novo Nordisk, Eli Lilly, and MDS. M.E.W. has received license fees from Becton Dickenson and has received patent applications. R.H. has received honoraria for speaking engagements from Medtronic, Life Scan, Novo Nordisk, Eli Lilly, Animas, and the Medtronic Advisory Panel; has received license fees from Becton Dickenson; and has received patent applications. No other potential conflicts of interest relevant to this article were reported.